Latin America Hypodermic Syringes & Needles Market - By Type (Syringes, Needles), By Usability (Disposable, Reusable), By Application (Blood Collection, Drug Delivery, Vaccination, Insulin Administration), By End-use & Global Forecast, 2023-2032

Industry Statistics

Latin America Hypodermic Syringes & Needles Market size was worth more than USD 375 million in 2022 and is poised to exhibit exponential growth at over 3% CAGR between 2023 and 2032 driven by the rising prevalence of chronic diseases.
 

To get more details on this report: Request Free Sample PDF
 

The substantial rise in patients suffering from noncommunicable diseases including obesity, diabetes, and cardiovascular diseases, among others, which contribute to prolonged hospitalization and high mortality rates, is anticipated to contribute to industry progress. According to the Centers for Disease Control and Prevention, Americans with chronic illnesses and mental health disorders account for 90% of the nation’s USD 3.8 trillion annual healthcare expenses. Hence, the surging usage of syringes and needles in the medical field, notably since the COVID-19 pandemic, for delivering vaccinations, is estimated to propel the market revenue.

Risk of needlestick injuries & infection to hamper business landscape

The rising incidence of injuries and infections caused by needles is likely to limit market development. Numerous blood-borne illnesses, including the human immunodeficiency virus (HIV) and hepatitis B (HBV), among others, are caused by a variety of needlestick injuries. As a result, the use of hypodermic needles may result in injuries and infections. However, healthcare professionals are increasingly turning to disposable needles and syringes, which greatly minimizes the risk of disease transmission.

Increasing number of injection-based treatments to augment needles segment share

To get more details on this report: Request Free Sample PDF
 

Needles segment accounted for around 53% revenue share of the Latin America hypodermic syringes & needles market in 2022 and is set to record substantial growth over 2023-2032. A hypodermic needle is essential in research that requires sterile conditions. Due to its sleek surface, airborne viruses do not get stuck on an uneven surface, which reduces contamination during sterile substrate injection, thereby contributing to its increasing adoption rate. Furthermore, the substantial rise in injection-based treatments and therapeutic systems is expected to positively influence segment expansion.
 

Surging investments by public health agencies to fuel drug delivery segment progress

To get more details on this report: Request Free Sample PDF
 

By application, Latin America hypodermic syringes & needles market from the drug delivery segment generated USD 183 million in 2022. The mounting product usage for delivery of pharmaceuticals during the treatments of a wide range of diseases along with the long-term strategies and investments by the state and federal public health partners to support the healthcare sector in overcoming the difficulties caused by the pandemic are likely to boost the segment share.
 

Convenience and safety benefits associated with the use of disposable syringes and needles to propel industry outlook

Based on usability, the Latin America hypodermic syringes & needles market from the disposable segment is projected to reach USD 506 million by 2032. In recent years, the increasing availability of ready-to-use sterilized disposable hypodermic syringes and needles has proven to be of significant convenience to medical professionals, hospitals, and nursing homes. Disposable syringes and needles are the most often used medical instruments for intravenous or intramuscular injections to avoid disease transmission since they are designed to be discarded after one use. Hence, these benefits of the product are set to promote their preference through 2032.
 

Surge in occurrences of chronic illnesses to increase product utilization in hospital settings

Latin America hypodermic syringes & needles market from the hospitals end-use segment is set to be worth more than USD 340 million by 2032 backed by the soaring number of diagnostic procedures and increasing patient admissions with chronic conditions, which is slated to propel product demand in hospitals. Thus, rising hospital visits and the upsurge in the incidences of chronic disorders, such as chronic respiratory conditions, diabetes, cancer, cardiovascular ailments, orthopedic disorders, and other conditions, are foreseen to positively influence the segment outlook.
 

High prevalence of diabetes to foster the Brazil market expansion

Get more details on this report: Request Free Sample PDF
 

Brazil hypodermic syringes & needles market is projected to amass more than USD 179 million in revenue by 2032. Brazil ranks third in the world in the prevalence of type 1 diabetes cases among children and adolescents aged between 0-14 years, which is expected to boost product usage. Additionally, industry participants are taking efforts to expand their services, which is likely to bolster market progression.
 

Product portfolio expansions to define the competitive landscape

Some major players operating in the Latin America hypodermic syringes & needles market are B. Braun Melsungen AG, Becton Dickinson, & Company, Cardinal Health, Inc., Terumo Corporation, Nipro Corporation, and Medline Industries, Inc., among others. To strengthen their market share, these organizations are frequently engaging in strategic efforts, such as collaborations and service portfolio expansions.

Latin America hypodermic syringes & needles market research report includes in-depth coverage of the industry with estimates & forecast in terms of USD Million from 2018 to 2032, for the following segments:

Click here to Buy Section of this Report

By Type

• Syringes
• Needles

By Usability

• Disposable
• Reusable

By Application

• Blood Collection
• Drug delivery
• Vaccination
• Insulin Administration
• Other 

By End-use

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers
• Others

The above information is provided for the following countries:

• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Urugua